BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2022 Earnings Call Transcript

Page 9 of 9

Operator: And we have no further questions in queue. I’ll turn the call back over to our Chairman and CEO, JJ Bienaimé.

JJ Bienaimé: Thank you, operator. Thank you for joining us on today’s call. We are very excited about all the developments occurring at BioMarin today. Obviously, we don’t know what the FDA decision is going to be on ROCTAVIAN. But needless to say, we are actively preparing for the launch of ROCTAVIAN in the U.S. Thank you. Bye.

Traci McCarty: Thank you, everybody. Bye, bye.

Operator: That concludes today’s conference call. Thank you for joining, and have a pleasant day.

Follow Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

Page 9 of 9